MedPath

A Controlled Study Evaluating Relative Benefits of Two Types of Review after an A&E Attendance

Completed
Conditions
Respiratory tract diseases: Asthma
Respiratory
Asthma
Registration Number
ISRCTN11122844
Lead Sponsor
Record Provided by the NHS R&D 'Time-Limited' National Programme Register - Department of Health (UK)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
300
Inclusion Criteria

300 patients attending A&E due to asthma will be entered into the study over 15 months and outcomes assessed for 12 months after entry.

Exclusion Criteria

Not provided at time of registration

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Re-attendance at Accident and Emergency and hospital admission, patient attendance at GP follow up, asthma medication prescriptions over the next 12 months, patient self management, morbidity and QOL at 1 month, 6 months and 12 months. A cost benefit analysis will be carried out.
Secondary Outcome Measures
NameTimeMethod
ot provided at time of registration
© Copyright 2025. All Rights Reserved by MedPath